Information for "Efficacy as well as security associated with tranexamic acidity consecutive rivaroxaban about blood loss inside aged sufferers in the course of back interbody fusion"
From EECH Central
Basic information
| Display title | Efficacy as well as security associated with tranexamic acidity consecutive rivaroxaban about blood loss inside aged sufferers in the course of back interbody fusion |
| Default sort key | Efficacy as well as security associated with tranexamic acidity consecutive rivaroxaban about blood loss inside aged sufferers in the course of back interbody fusion |
| Page length (in bytes) | 3,355 |
| Page ID | 1414350 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Storyturtle8 (Talk | contribs) |
| Date of page creation | 08:48, 28 April 2024 |
| Latest editor | Storyturtle8 (Talk | contribs) |
| Date of latest edit | 08:48, 28 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
